Aging and dyslipidemia: A review of potential mechanisms

被引:190
作者
Liu, Hui-Hui [2 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci, Fu Wai Hosp, Natl Ctr Cardiovasc Dis, Div Dyslipidemia,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100037, Peoples R China
基金
北京市自然科学基金; 高等学校博士学科点专项科研基金;
关键词
Dyslipidemia; Aging; Lipoprotein metabolism; Cardiovascular disease; LOW-DENSITY-LIPOPROTEIN; PROLIFERATOR-ACTIVATED RECEPTOR; AGE-RELATED-CHANGES; CORONARY-ARTERY-DISEASE; GROWTH-HORMONE TREATMENT; FREE FATTY-ACIDS; INSULIN-RESISTANCE; RISK-FACTORS; PPAR-ALPHA; CARDIOVASCULAR-DISEASE;
D O I
10.1016/j.arr.2014.12.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Elderly adults constitute a rapidly growing part of the global population, thus resulting in an increase in morbidity and mortality related to cardiovascular disease (CVD), which remains the major cause of death in elderly population, including men and women. Dyslipidemia is a well-established risk factor for CVD and is estimated to account for more than half of the worldwide cases of coronary artery disease (CAD). Many studies have shown a strong correlation between serum cholesterol levels and risk of developing CAD. In this paper, we review the changes of plasma lipids that occur in men and women during aging and the potential mechanisms of age-related disorders of lipoprotein metabolism covering humans and/or animals, in which changes of the liver sinusoidal endothelium, postprandial lipemia, insulin resistance induced by free fatty acid (FFA), growth hormone (GH), androgen (only for men) and expression and activity of peroxisome proliferator-activated receptor alpha (PPAR alpha) are mainly focused. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 136 条
  • [11] Bjorntorp Per, 1992, Journal of Cardiovascular Pharmacology, V20, pS26
  • [12] MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE
    BODEN, G
    CHEN, XH
    RUIZ, J
    WHITE, JV
    ROSSETTI, L
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) : 2438 - 2446
  • [13] BONADONNA RC, 1994, AM J PHYSIOL, V266, pE501
  • [14] Growth hormone therapy in elderly people: An age-delaying drug?
    Bouillanne, O
    Rainfray, M
    Tissandier, O
    Nasr, A
    Lahlou, A
    Cnockaert, X
    Piette, F
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1996, 10 (05) : 416 - 430
  • [15] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
    Braissant, O
    Foufelle, F
    Scotto, C
    Dauca, M
    Wahli, W
    [J]. ENDOCRINOLOGY, 1996, 137 (01) : 354 - 366
  • [16] LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZE AND CORONARY-ARTERY DISEASE
    CAMPOS, H
    GENEST, JJ
    BLIJLEVENS, E
    MCNAMARA, JR
    JENNER, JL
    ORDOVAS, JM
    WILSON, PWF
    SCHAEFER, EJ
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02): : 187 - 195
  • [17] Age-related differences in inflammatory markers in men: contribution of visceral adiposity
    Cartier, Amelie
    Cote, Melanie
    Lemieux, Isabelle
    Perusse, Louis
    Tremblay, Angelo
    Bouchard, Claude
    Despres, Jean-Pierre
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (10): : 1452 - 1458
  • [18] USEFULNESS OF SEX STEROID-HORMONE LEVELS IN PREDICTING CORONARY-ARTERY DISEASE IN MEN
    CAULEY, JA
    GUTAI, JP
    KULLER, LH
    DAI, WS
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (10) : 771 - 777
  • [19] Hepatic sinusoidal pseudocapillarization with aging in the non-human primate
    Cogger, VC
    Warren, A
    Fraser, R
    Ngu, M
    McLean, AJ
    Le Couteur, DG
    [J]. EXPERIMENTAL GERONTOLOGY, 2003, 38 (10) : 1101 - 1107
  • [20] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3